Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the
|
|
- Evan Park
- 6 years ago
- Views:
Transcription
1 Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the presentation July 16, 2012 and should not be considered current after that date.
2 Thermo Fisher Scientific to Acquire One Lambda July 16, The world leader in serving science
3 Safe Harbor Statement / Use of Non-GAAP Financial Measures The following constitutes t a "Safe Harbor" statement t t under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in Thermo Fisher's most recent quarterly report, under the caption Risk Factors, which is on file with the Securities and Exchange Commission and available on Thermo Fisher's website. Additional important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the need to develop new products and adapt to significant technological change; implementation of strategies for improving growth; general worldwide economic conditions including economic conditions in the countries in which Thermo Fisher and sell products, and related uncertainties; dependence on customers' capital spending policies and government funding policies; the effect of exchange rate fluctuations on international operations; the effect of healthcare reform legislation; use and protection of intellectual property; p the effect of changes in governmental regulations; and the effect of laws and regulations governing g government contracts, as well as the possibility that expected benefits related to the transaction may not materialize as expected; the transaction not being timely completed, if completed at all; prior to the completion of the transaction, One Lambda s business experiencing disruptions due to transaction-related uncertainty or other factors making it more difficult to maintain relationships with employees, licensees, other business partners or governmental entities; and the parties being unable to successfully implement integration strategies. While Thermo Fisher may elect to update forward-looking statements at some point in the future, Thermo Fisher specifically disclaims i any obligation to do so, even if estimates t change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today. In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), we use certain non-gaap financial a measures, es, including adjusted EPS, adjusted operating income, and adjusted EBITDA, which exclude restructuring and other costs/income and amortization of acquisition-related intangible assets. Adjusted EPS also excludes certain other gains and losses, tax provisions/benefits related to the previous items, benefits from tax credit carryforwards, the impact of significant tax audits or events and discontinued operations. We exclude the above items because they are outside of our normal operations and/or, in certain cases, are difficult to forecast accurately for future periods. We believe that the use of non- GAAP measures helps investors to gain a better understanding of our core operating results and future prospects, consistent with how management measures and forecasts the company's performance, especially when comparing such results to previous periods or forecasts. 2
4 One Lambda Creating Shareholder Value One Lambda the global leader in transplant diagnostics Consistent with our specialty in vitro diagnostics strategy Complements our immunosuppressant drug monitoring product offering Creates opportunity to leverage commercial infrastructure in emerging markets $925 million purchase price funded with cash and new debt Financially compelling Immediately accretive, solid return, attractive valuation Expected to close in Q4 of 2012 Customary regulatory approvals Further enhances our leadership in specialty diagnostics 3
5 One Lambda The Clear Global Leader in Transplant Diagnostics Serology 7% 2011 Revenue World leader in transplant diagnostics 2011 revenue: $182 million HLA Typing 44% Antibody Detection 49% 1,400 customers Transplant centers HLA clinical, academic and research testing labs Clinicians Headquartered in Canoga Park, California 320 employees Asia Pacific 5% Brazil 10% ROW 5% Europe 21% North America 59% 4
6 Transplant Diagnostics is an Attractive Market $480 million market in 2011, growing mid- to high-single digits Growth of transplant diagnostics market driven by: Increasing global demand for transplant procedures Increasing utilization (i.e., tests per patient) Growing use of post-transplant antibody monitoring i due to new scientific ifi evidence showing continued antibody monitoring improves graft survival New drug therapy enables a compelling companion diagnostics opportunity Transplant Testing Workflow Cross- HLA Typing Screening Identification Transplant Matching Post-Transplant Monitoring One Lambda is the leader in transplant diagnostics 5 Source: Scientia Advisors Analysis
7 Increases Our Depth of Capabilities in Specialty Diagnostics Thermo Fisher Specialty Diagnostics Segment Healthcare Market Channel Anatomical Pathology Microbiology Clinical Assays One Lambda Immunodiagnostics Strong Strategic Fit Markets Expands presence in attractive and growing market segment Opportunity to leverage Thermo Fisher s strength in emerging markets Technologies Enhances Thermo Fisher offering in immune-response diagnostics space Customers Leverage One Lambda s deep, longstanding customer relationships Pro Forma Revenues* $3.0B 6 * Revenues based on LTM ending 3/31/12
8 Significant Financial Benefits Create Shareholder Value Expected to be immediately accretive to adjusted EPS and add approximately $0.09 -$0.11 in 2013 Synergies Expect total t adjusted d operating income benefit of approximately $15 million in 2015 Net of approximately $10 million of incremental investments to improve operating processes and fund development Opportunity to leverage Thermo Fisher s global infrastructure and commercial presence to accelerate growth Tax efficiencies from leveraging Thermo Fisher s global structure 338(h)(10) election to provide significant cash tax benefit Creates annual cash tax savings of approximately $19 million for 15 years, resulting in $190 million NPV tax benefit Attractive purchase price multiple Implied 2011 EBITDA purchase price multiple of 10.9x Including value of 338(h)(10) tax benefit, implied 2011 EBITDA purchase price multiple of 8.7x Transaction ROIC expected to exceed WACC in
9 Consistently Returning Capital to Our Shareholders Share Repurchase Program Board of Directors authorized an additional $500 million share repurchase program effective 7/15/12 expires 12/31/12 $250 million remaining of existing $750 million repurchase authorization $400 million spent in first half of 2012 and $100 million in Q Total of $750 million available for the remainder of 2012 Dividend Board of Directors authorized first dividend in early 2012 Initial quarterly dividend of $0.13 paid April 16 Subsequent dividends of $0.13 payable July 15, October 15 8
10 One Lambda Creating Shareholder Value Very well aligned with our specialty diagnostics strategy Further enhances our leadership in specialty diagnostics Financially compelling transaction 9
Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the
Please note that the following presentation contains financial projections and other forward-looking statements that are specific to the date of the presentation January 13, 2015 and should not be considered
More informationjuly 2012 CEB to Acquire SHL Compelling Value Creation, Growth, and Scale Opportunity
july 2012 CEB to Acquire SHL Compelling Value Creation, Growth, and Scale Opportunity Safe Harbor Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities
More informationGAAP/Non-GAAP Reconciliation and Financial Package October 27, 2016
GAAP/Non-GAAP Reconciliation and Financial Package October 27, 2016 The World Leader in Serving Science Use of Non-GAAP Financial Measures In addition to the financial measures prepared in accordance with
More informationWILLIAM BLAIR GROWTH STOCK CONFERENCE JUNE 12, 2018 CHICAGO, IL
WILLIAM BLAIR GROWTH STOCK CONFERENCE JUNE 12, 2018 CHICAGO, IL FORWARD LOOKING STATEMENT AND USE OF ADJUSTED MEASURES This presentation contains forward-looking statements including but not limited to
More informationSYNNEX Concentrix Division Announces the Acquisition of Convergys
Filed by SYNNEX Corporation pursuant to Rule 425 under the Securities Act of 1933, as amended and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended Subject Company:
More informationUBS Healthcare Conference John J. Greisch, President and CEO. May 22, 2017
UBS Healthcare Conference John J. Greisch, President and CEO May 22, 2017 Forward Looking Statements This presentation contains forward-looking statements, within the meaning of the Private Securities
More informationGAAP/Non-GAAP Reconciliation and Financial Package February 28, 2018
The Balance Sheet on page 10 of this document has been updated from the version published on January 31, 2018 to reflect final numbers as published in the Thermo Fisher Scientific Inc. Form 10-K for the
More informationDiplomat s Acquisition of LDI Integrated Pharmacy Services. Nov. 15, 2017
Diplomat s Acquisition of LDI Integrated Pharmacy Services Nov. 15, 2017 1 DISCLAIMERS NON-GAAP INFORMATION We define Adjusted EBITDA as net income (loss) before interest expense, income taxes, depreciation
More informationXylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016
1 Xylem Agrees to Acquire Sensus to Broaden Portfolio and Enhance Growth Platform AUGUST 15, 2016 Forward-Looking Statements This presentation contains information that may constitute forward-looking statements.
More information+ September 12, 2017
+ September 12, 2017 Safe Harbor Statement CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This document contains certain forward-looking statements with respect to the financial condition, results
More informationAcquisition of Dealer Inspire and Launch Digital Marketing
Acquisition of Dealer Inspire and Launch Digital Marketing Investor Presentation February 14, 2018 Forward Looking Statements This presentation contains forward looking statements within the meaning of
More informationGAAP/Non-GAAP Reconciliation and Financial Package
GAAP/Non-GAAP Reconciliation and Financial Package April 25, 2018 The world leader in serving science Use of Non-GAAP Financial Measures In addition to the financial measures prepared in accordance with
More informationHill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016
Hill-Rom Fourth Quarter 2016 Financial Results November 3, 2016 Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private
More informationESI Announcement 10/30/2018
ESI Announcement 10/30/2018 Safe Harbor for Forward Looking Statements Statements in this presentation regarding the proposed transaction between MKS Instruments, Inc. ( MKS ) and Electro Scientific Industries
More informationGSI Group to Acquire NDS Surgical Imaging for $82.5 Million
FOR IMMEDIATE RELEASE January 15, 2013 GSI Group to Acquire NDS Surgical Imaging for $82.5 Million NDS is the leading producer of high performance visualization products sold to OEMs in the surgical endoscopy
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Healthcare Conference, September 2017 NASDAQ: NOVT 1 Safe Harbor Statement The statements in this presentation
More informationZimmer Biomet Reports Second Quarter 2016 Financial Results
July 28, 2016 Zimmer Biomet Reports Second Quarter 2016 Financial Results -- Net Sales of $1.934 billion represent an increase of 65.6% over the prior year period, and an increase of 4.5% on an adjusted
More informationGAAP/Non-GAAP Reconciliation and Financial Package
GAAP/Non-GAAP Reconciliation and Financial Package January 8, 2018 The world leader in serving science Use of Non-GAAP Financial Measures In addition to the financial measures prepared in accordance with
More informationEnergizer to Acquire Spectrum Brands Global Battery and Portable Lighting Business. January 16, 2018
Energizer to Acquire Spectrum Brands Global Battery and Portable Lighting Business January 16, 2018 Safe Harbor Statement Unless the context otherwise requires, references in this presentation to Energizer,
More informationPolyOne Investor Presentation Credit Suisse Boston Basic Materials Conference. June 26, 2013
PolyOne Investor Presentation Credit Suisse Boston Basic Materials Conference June 26, 2013 Forward Looking Statements In this presentation, statements that are not reported financial results or other
More informationLPL Financial. Purchase of National Planning Holdings, Inc. August 15, Member FINRA/SIPC
LPL Financial Purchase of National Planning Holdings, Inc. August 15, 2017 Member FINRA/SIPC Notice to Investors: Safe Harbor Statement Statements in this presentation regarding LPL Financial Holdings
More informationLOOKING statements. Forward
1 Forward LOOKING statements This presentation contains forward-looking statements regarding future events or the future financial performance of the Company that involve substantial risks and uncertainties.
More informationIDEXX Laboratories Announces Third Quarter Results
FOR IMMEDIATE RELEASE Contact: Kerry Bennett, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces Third Quarter Results Reports revenue growth of 11% on a reported basis and 12% on an organic
More informationUnited Rentals to Acquire RSC Holdings
United Rentals to Acquire RSC Holdings Investor Presentation DECEMBER 2011 Introductory Information Cautionary Statement Regarding Forward-Looking Statements This document contains forward-looking statements
More informationMagellan Health. Cantor Fitzgerald Healthcare Conference September 26, 2017
Magellan Health Cantor Fitzgerald Healthcare Conference September 26, 2017 Cautionary Statement and Non-GAAP measures 2 This slide presentation and our accompanying oral comments include forward-looking
More informationWilliam Blair 35 th Annual Growth Stock Conference. June 9, 2015 NYSE: Q. Copyright 2014 Quintiles
William Blair 35 th Annual Growth Stock Conference June 9, 2015 Copyright 2014 Quintiles NYSE: Q Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking
More informationNews from Aon Aon Reports Fourth Quarter and Full Year 2018 Results Fourth Quarter Key Metrics as Reported Under U.S. GAAP(1)
Investor Relations News from Aon Aon Reports Fourth Quarter and Full Year Results Fourth Quarter Key Metrics as Reported Under U.S. GAAP (1) Total revenue decreased 5 to $2.8 billion, including a decrease
More informationAcquisition Offer of RPC Group PLC
Always Advancing To Protect What s Important Acquisition Offer of RPC Group PLC March 2019 NYSE: BERY Safe Harbor Statements THIS PRESENTATION AND ITS CONTENTS ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION,
More informationJune 8, Acquisitions Update Call
June 8, 2018 Acquisitions Update Call Certain statements contained in this presentation that are not historical facts, including any statements as to future market conditions, results of operations, and
More informationCombination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014
Combination Creates Leading Innovator in the Musculoskeletal Industry April 24, 2014 David Dvorak President and Chief Executive Officer Jim Crines EVP, Finance, and Chief Financial Officer Cautionary Statement
More informationIDEXX Laboratories Announces Second Quarter Results
FOR IMMEDIATE RELEASE Contact: Ed Garber, Director, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces Second Quarter Results Delivers 9% organic revenue growth and $1.10 EPS, driven by double-digit
More informationIngersoll Rand s Acquisition of Precision Flow Systems (PFS) February 11, 2019
Ingersoll Rand s Acquisition of Precision Flow Systems (PFS) February 11, 2019 1 Safe Harbor This presentation contains forward-looking statements, which are statements that are not historical facts, including
More informationEarnings Presentation October 25, 2018
nvent Third Quarter 2018 Earnings Presentation October 25, 2018 Forward-Looking Statement CAUTION CONCERNING FORWARD-LOOKING STATEMENTS This presentation contains statements that we believe to be "forward-looking
More informationInnovation with Integrity. Bruker Corporation
Bruker drives profitable growth and margin expansion by enabling scientific discoveries and by delivering highperformance analytical, life science and diagnostic solutions Bruker Corporation Innovation
More informationPolyOne Investor Presentation KeyBanc 2014 Basic Materials & Packaging Conference Boston, MA September 10, 2014
PolyOne Investor Presentation KeyBanc 2014 Basic Materials & Packaging Conference Boston, MA September 10, 2014 PolyOne Corporation Page 1 Forward-Looking Statements In this presentation, statements that
More informationIDEXX Laboratories Announces First Quarter Results
FOR IMMEDIATE RELEASE Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155 IDEXX Laboratories Announces First Quarter Results WESTBROOK, Maine, IDEXX Laboratories, Inc. (NASDAQ: IDXX), today
More informationAcquisition of Astra Tech June 22, 2011 NASDAQ-XRAY
Acquisition of Astra Tech June 22, 2011 1 Forward Looking Statements This presentation, in addition to historical information, contains forward-looking statements (as defined in the Securities Litigation
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. Aon plc (Exact Name of Registrant as Specified in Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event
More information2018 SECOND QUARTER FINANCIAL RESULTS
2018 SECOND QUARTER FINANCIAL RESULTS July 30, 2018 0 SAFE HARBOR STATEMENT The 2018 second quarter news release, conference call webcast, and the following slides contain forward-looking statements. The
More informationNews from Aon Aon Reports Fourth Quarter and Full Year 2017 Results Fourth Quarter Key Metrics From Continuing Operations and Highlights
Investor Relations News from Aon Aon Reports Fourth Quarter and Full Year Results Fourth Quarter Key Metrics From Continuing Operations and Highlights Reported revenue increased 10 to $2.9 billion with
More informationBruker Corporation (NASDAQ: BRKR)
Bruker Corporation (NASDAQ: BRKR) Q4 2017 Earnings Presentation February 8, 2018 Frank Laukien, President & CEO Anthony Mattacchione, SVP & CFO Miroslava Minkova, Head of Investor Relations Innovation
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. Aon plc (Exact Name of Registrant as Specified in Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event
More informationGAAP/Non-GAAP Reconciliation and Financial Package
GAAP/Non-GAAP Reconciliation and Financial Package October 24, 2018 The world leader in serving science Use of Non-GAAP Financial Measures In addition to the financial measures prepared in accordance with
More informationFiserv Investor Conference Call. January 14, 2013
Fiserv Investor Conference Call January 14, 2013 Forward-Looking Statements and Non-GAAP Financial Information The information disclosed in this presentation contains forward-looking statements, including
More informationThe Hartford Financial Services Group, Inc. December 2017 Overview of The Hartford
The Hartford Financial Services Group, Inc. December 2017 Overview of The Hartford Copyright 2017 by The Hartford. All rights reserved. No part of this document may be reproduced, published or posted without
More informationMSCI. Raymond James 38 th Annual Institutional Investors Conference. Kathleen Winters, CFO. March 8, 2017
MSCI Raymond James 38 th Annual Institutional Investors Conference Kathleen Winters, CFO March 8, 2017 2017 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. FORWARD
More informationReports Strong Net New Bookings and Recurring Revenue for Fiscal Year 2017
Press Release Nuance Announces Fourth Quarter and Fiscal Year 2017 Results Reports Strong Net New Bookings and Recurring Revenue for Fiscal Year 2017 BURLINGTON, Mass., (NASDAQ: NUAN) today announced financial
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event
More informationIDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event
More informationAon plc. First Quarter 2017 Results May 9, 2017
Aon plc First Quarter 2017 Results May 9, 2017 Greg Case Chief Executive Officer Christa Davies Chief Financial Officer 1 Safe Harbor Statement This communication contain certain statements related to
More informationRaymond James 37 th Annual Institutional Investors Conference. March 8, 2016
Raymond James 37 th Annual Institutional Investors Conference March 8, 2016 Forward-looking statements and Non-GAAP financial measures Forward-looking statements Certain statements included in this presentation,
More informationZebra Technologies Second-Quarter 2018 Results. August 7, 2018
Zebra Technologies Second-Quarter 2018 Results August 7, 2018 Safe Harbor Statement Statements made in this presentation which are not statements of historical fact are forward-looking statements and are
More informationFirst Quarter 2018 Financial Results. January 26, 2018
First Quarter 2018 Financial Results January 26, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. All statements included
More informationINVESTOR PRESENTATION MAY 2017
INVESTOR PRESENTATION MAY 2017 FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL INFORMATION Forward-Looking Statements Certain statements and information in this communication may be deemed to be forward-looking
More informationJarden Investor Presentation. October 14, 2015
Jarden Investor Presentation October 14, 2015 Cautionary Statement Please note that in this presentation, we may discuss events or results that have not yet occurred or been realized, commonly referred
More informationInvestor Presentation. February 2018
Investor Presentation February 2018 1 Forward Looking Statements Important Information About Littelfuse, Inc. This presentation does not constitute or form part of, and should not be construed as, an offer
More informationDave Carlucci Chairman and CEO IMS Health
Dave Carlucci Chairman and CEO IMS Health 1 March 11, 2009 Safe Harbor Certain statements we make today are forward-looking within the meaning of the US federal securities laws. These statements include,
More informationIDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event
More informationMyriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results
May 8, 2018 Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results Total Revenues of $193.5 Million GAAP Diluted EPS of $0.16 and Adjusted EPS of $0.31 Up 15 Percent Company Raises Both Revenue
More informationLABCORP ANNOUNCES 2018 SECOND QUARTER RESULTS AND UPDATES 2018 GUIDANCE
FOR IMMEDIATE RELEASE Contact: Scott Frommer (investors) 336-436-5076 Investor@labcorp.com Pattie Kushner (media) 336-436-8263 Media@labcorp.com LABCORP ANNOUNCES 2018 SECOND QUARTER RESULTS AND UPDATES
More informationJune Dear Fellow Takeda Shareholder,
June 2018 Dear Fellow Takeda Shareholder, Since joining Takeda in April 2014, my mission has been to continue the transformation of Takeda in order to ensure that Takeda will be a successful company in
More informationStaples, Inc. Details Corporate Express Integration Plans and Announces Preliminary Second Quarter Performance
Media Contact: Investor Contact: Paul Capelli/Owen Davis 508-253-8530/8468 Laurel Lefebvre/Chris Powers 508-253-4080/4632 Staples, Inc. Details Corporate Express Integration Plans and Announces Preliminary
More informationAllscripts Healthcare Solutions
Allscripts Healthcare Solutions J A N U A R Y 2 0 1 9 J.P. Morgan Healthcare Conference Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More informationAmcor & Bemis Combination Creating the Global Leader in Consumer Packaging. 6 August 2018
Amcor & Bemis Combination Creating the Global Leader in Consumer Packaging 6 August 2018 Disclaimer Cautionary Statement Regarding Forward-Looking Statements This communication contains certain statements
More informationThe Hartford Financial Services Group, Inc. November 2017 Overview of The Hartford
The Hartford Financial Services Group, Inc. November 2017 Overview of The Hartford Copyright 2017 by The Hartford. All rights reserved. No part of this document may be reproduced, published or posted without
More informationZEBRA TECHNOLOGIES SECOND-QUARTER 2016 RESULTS. August 9, 2016
ZEBRA TECHNOLOGIES SECOND-QUARTER 2016 RESULTS August 9, 2016 Anders Gustafsson Chief Executive Officer Mike Smiley Chief Financial Officer 2 Safe Harbor Statement Statements made in this presentation
More informationCapturing the Opportunity
Capturing the Opportunity JANUARY 2018 BETHANY DIPLOMAT PATIENT Copyright 2018 by Diplomat Pharmacy Inc. Diplomat is a registered trademark of Diplomat Pharmacy Inc. All rights reserved. 1 SPECIALTY DRUGS
More informationCompelling Strategic Transaction
ACQUISITION OF DJO GLOBAL November 19, 2018 Forward Looking Statements & Non-GAAP Disclaimer The following information may contain forward-looking statements, including forward-looking statements within
More informationInfuSystem Holdings, Inc. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationIDEXX Laboratories Announces First Quarter Results
FOR IMMEDIATE RELEASE Contact: Kerry Bennett, Investor Relations, 1-207-556-8155 IDEXX Laboratories Announces First Quarter Results Reports revenue growth of 11% on both a reported and organic basis, driven
More informationSafe Harbor Statement
January 3, 2018 Safe Harbor Statement Statements in this presentation that are not historical, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation
More informationMylan Reports Third Quarter 2017 Results and Updates 2017 Guidance
November 6, Mylan Reports Third Quarter Results and Updates Guidance HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced its financial results
More informationDMS Health Technologies, Inc. ACQUISITION OVERVIEW OCTOBER 14, 2015
DMS Health Technologies, Inc. ACQUISITION OVERVIEW OCTOBER 14, 2015 FORWARD-LOOKING STATEMENTS Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The presentation and information
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Industrial Conference, November 2017 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement
More informationSecond Quarter 2017 Reconciliation of Non-GAAP Financial Measures
Second Quarter 2017 Reconciliation of Non-GAAP Financial Measures Adjusted Operating Income Reconciliation Adjusted operating income is not a measure of financial performance under generally accepted accounting
More informationAvery Dennison. Baird 2018 Global Industrial Conference. Mitch Butier President and Chief Executive Officer. November 8, 2018
Avery Dennison November 8, 2018 Mitch Butier President and Chief Executive Officer 1 Forward-Looking Statements Certain statements contained in this document are "forward-looking statements" intended to
More informationESTABLISHING A GLOBAL LEADER IN WORKWEAR 1. August 14, 2017
ESTABLISHING A GLOBAL LEADER IN WORKWEAR 1 August 14, 2017 FORWARD-LOOKING STATEMENTS Certain statements included in this presentation are "forward-looking statements" within the meaning of the federal
More informationInvestor Presentation June 18, 2014 TE CONNECTIVITY ACQUIRES MEASUREMENT SPECIALTIES
Investor Presentation June 18, 2014 TE CONNECTIVITY ACQUIRES MEASUREMENT SPECIALTIES Forward-Looking Statements Forward Looking Statements This presentation contains certain forward-looking statements
More informationAon Reports First Quarter 2018 Results
Investor Relations News from Aon Aon Reports First Quarter 2018 Results First Quarter Key Metrics as Reported under U.S. GAAP (1) Total revenue increased 30% to $3.1 billion, including an increase of $365
More informationFOR IMMEDIATE RELEASE
Company Investor/Media Contact: DJO Incorporated Mark Francois, Director of Investor Relations (760) 734-4766 mark.francois@djoglobal.com FOR IMMEDIATE RELEASE DJO INCORPORATED ANNOUNCES FINANCIAL RESULTS
More informationDANAHER TO ACQUIRE GE LIFE SCIENCES BIOPHARMA BUSINESS ( GE Biopharma ) February 25, 2019
DANAHER TO ACQUIRE GE LIFE SCIENCES BIOPHARMA BUSINESS ( GE Biopharma ) February 25, 2019 Forward Looking Statements Statements in this presentation and the accompanying call that are not strictly historical,
More informationA Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers
A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers February 2018 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement The statements in this
More information22 nd Annual Credit Suisse Healthcare Conference. November 12, nd Annual Credit Suisse Healthcare Conference November 12, 2013.
22 nd Annual Credit Suisse Healthcare Conference November 12, 2013 1 Safe Harbor For Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of
More informationFiserv to Combine with First Data to Create Global Leader in Payments and FinTech
Fiserv to Combine with First Data to Create Global Leader in Payments and FinTech Investor Presentation January 6, 209 Forward Looking Statements The information disclosed in this presentation contains
More informationGabelli Pump, Valve and Water Systems Symposium
Advanced Flow Solutions Energy Pumping Technologies Gabelli Pump, Valve and Water Systems Symposium Scott Buckhout President & CEO 1 February 22, 2018 1 Safe Harbor This presentation contains forward-looking
More informationDunbar Acquisition Strengthening Our U.S. Operations
Dunbar Acquisition Strengthening Our U.S. Operations MAY 31, 2018 Safe Harbor Statement and Non-GAAP Results These materials contain forward-looking information. Words such as "anticipate," "assume," "estimate,"
More informationForward-Looking Statements
William Blair & Company 27 th Annual Growth Stock Conference June 20, 2007 0 Forward-Looking Statements This presentation contains forward-looking statements that are subject to a number of risks and uncertainties,
More informationSS&C Technologies (NASDAQ:SSNC)
SS&C Technologies (NASDAQ:SSNC) Leading Software Provider to the Institutional, Alternative and Wealth Management Markets SS&C to Acquire DST Systems January 11, 2018 Safe Harbor Statement Safe Harbor
More informationInvestor Relations Hologic
Investor Relations Hologic Hologic Announces Financial Results for Second Quarter of Fiscal 2017 -- GAAP Diluted EPS of $1.84 Increases 666.7%, Non-GAAP Diluted EPS of $0.50 Increases 6.4% -- -- Revenue
More informationEcolab Acquisition of Champion
Ecolab Acquisition of Champion Strengthening opportunities and positions in the fast-growing energy services markets October 12, 2012 1 Cautionary Statement Cautionary Statements Regarding Forward-Looking
More informationMyriad Genetics Reports Fiscal Fourth-Quarter 2017 and Fiscal Full-Year 2017 Financial Results
August 8, 2017 Myriad Genetics Reports Fiscal Fourth-Quarter 2017 and Fiscal Full-Year 2017 Financial Results Total Revenues of $200.5 Million Up 8 Percent GAAP Diluted EPS was $0.19 and Adjusted EPS of
More informationUnited Rentals to Acquire NES Rentals
United Rentals to Acquire NES Rentals Investor Presentation January 25, 2017 Introductory Information This presentation contains forward-looking statements within the meaning of Section 21E of the Securities
More informationFirst Quarter 2017 Earnings Call Presentation. April 26, 2017
First Quarter 2017 Earnings Call Presentation April 26, 2017 1 Forward-Looking Statements / Safe Harbor This presentation contains forward-looking statements, including statements regarding the proposed
More informationGartner to Acquire CEB for $2.6 Billion in Cash and Stock
Gartner to Acquire CEB for $2.6 Billion in Cash and Stock Creates the Leading Global Research and Advisory Company for All Major Functions in the Enterprise Gartner s Proven Operational Expertise and Sustained
More informationJ.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference John J. Greisch, President and CEO January 9, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform
More informationAcquisition of PARAGARD IUD from Teva September 11, 2017
Acquisition of PARAGARD IUD from Teva Forward Looking Statements Forward Looking Statements This earnings release contains "forward looking statements" as defined by the Private Securities Litigation Reform
More informationDANAHER CORPORATION Second Quarter 2018 Earnings Release. July 19, 2018
DANAHER CORPORATION Second Quarter 2018 Earnings Release July 19, 2018 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding the
More information4Q 2017 Presentation. February 27, 2018
4Q 2017 Presentation February 27, 2018 SAFE HARBOR Statements contained in this presentation that are not historical and reflect our views about future periods and events, including our future performance,
More informationInvestor Presentation
Investor Presentation J.P. Morgan 36 th Annual Healthcare Conference San Francisco, CA January 2018 Forward-Looking Statements This presentation contains forward-looking statements (as defined in the Securities
More information